Dr. Behnood Bikdeli and Dr. C. Michael Gibson Discuss: HI-PRO (Apixaban vs Placebo to Prevent Recurrences in Provoked Venous Thromboembolism With Enduring Risk Factors: One-Year Extension Results From the HI-PRO Trial) November 7, 2026 2026 | AHA | Slides | Trial | Video Bikdeli AHA 2026Download Disclosures: TBD Article Navigation Dr. Todd Villines and Dr. C. Michael Gibson Discuss: PARAMOUNT (A Randomized Comparison of Personalized Management for Medical and Interventional Therapy Based on Coronary Atherosclerotic Plaque versus Usual Care for Symptomatic Patients With Suspicion of Coronary Artery Disease: Primary Results of the PARAMOUNT Trial) Dr. Lindsey Rosman and Dr. C. Michael Gibson Discuss: Rethinking Atrial Fibrillation (AF) Burden: AF Density Further Stratifies Heart Failure Risk in a Nationwide Cohort of Patients with Cardiac Devices
